<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54166</article-id><article-id pub-id-type="doi">10.7554/eLife.54166</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-167709"><name><surname>Nassar</surname><given-names>Zeyad D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7779-2697</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167710"><name><surname>Mah</surname><given-names>Chui Yan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8820-4037</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167711"><name><surname>Dehairs</surname><given-names>Jonas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167712"><name><surname>Burvenich</surname><given-names>Ingrid JG</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167713"><name><surname>Irani</surname><given-names>Swati</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167714"><name><surname>Centenera</surname><given-names>Margaret M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195567"><name><surname>Helm</surname><given-names>Madison</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167715"><name><surname>Shrestha</surname><given-names>Raj K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167716"><name><surname>Moldovan</surname><given-names>Max</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167717"><name><surname>Don</surname><given-names>Anthony S</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195568"><name><surname>Holst</surname><given-names>Jeff</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167718"><name><surname>Scott</surname><given-names>Andrew M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167719"><name><surname>Horvath</surname><given-names>Lisa G</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167720"><name><surname>Lynn</surname><given-names>David J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-156232"><name><surname>Selth</surname><given-names>Luke A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167721"><name><surname>Hoy</surname><given-names>Andrew J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167722"><name><surname>Swinnen</surname><given-names>Johannes V</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-146475"><name><surname>Butler</surname><given-names>Lisa M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2698-3220</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Medicine</institution>, <institution>University of Adelaide</institution>, <addr-line><named-content content-type="city">Adelaide</named-content></addr-line>, <country>Australia</country></aff><aff id="aff2"><institution content-type="dept">Oncology</institution>, <institution>KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><aff id="aff3"><institution content-type="dept">Tumour Targeting Laboratory</institution>, <institution>Olivia Newton-John Cancer Research Institute</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><aff id="aff4"><institution content-type="dept">Precision Medicine</institution>, <institution>South Australian Health and Medical Research Institute</institution>, <addr-line><named-content content-type="city">Adelaide</named-content></addr-line>, <country>Australia</country></aff><aff id="aff5"><institution content-type="dept">Charles Perkins Centre</institution>, <institution>University of Sydney</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff6"><institution content-type="dept">School of Medical Sciences</institution>, <institution>University of New South Wales</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff7"><institution content-type="dept">Oncology</institution>, <institution>Chris O'Brien Lifehouse</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-63658"><name><surname>Sharifi</surname><given-names>Nima</given-names></name><role>Reviewing editor</role><aff><institution>Cleveland Clinic</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>lisa.butler@adelaide.edu.au</email> (LB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>07</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e54166</elocation-id><history><date date-type="received"><day>04</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>16</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Nassar et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Nassar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54166-v1.pdf"/><abstract><p>Fatty acid β-oxidation (FAO) is the main bioenergetic pathway in human prostate cancer (PCa) and a promising novel therapeutic vulnerability. Here we demonstrate therapeutic efficacy of targeting FAO in clinical prostate tumors cultured <italic>ex vivo, </italic>and identify<italic> DECR1, </italic>encoding the rate-limiting enzyme for oxidation of polyunsaturated fatty acids (PUFAs), as robustly overexpressed in PCa tissues and associated with shorter relapse-free survival. <italic>DECR1</italic> is a negatively-regulated androgen receptor (AR) target gene and, therefore, may promote PCa cell survival and resistance to AR targeting therapeutics. DECR1 knockdown selectively inhibited β-oxidation of PUFAs, inhibited proliferation and migration of PCa cells, including treatment resistant lines, and suppressed tumor cell proliferation and metastasis in mouse xenograft models. Mechanistically, targeting of DECR1 caused cellular accumulation of PUFAs, enhanced mitochondrial oxidative stress and lipid peroxidation, and induced ferroptosis. These findings implicate PUFA oxidation via DECR1 as an unexplored facet of FAO that promotes survival of PCa cells.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>Early Career Fellowship,1138648</award-id><principal-award-recipient><name><surname>Nassar</surname><given-names>Zeyad D</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004040</institution-id><institution>KU Leuven</institution></institution-wrap></funding-source><award-id>Project Grants C16/15/073 and C32/17/052</award-id><principal-award-recipient><name><surname>Swinnen</surname><given-names>Johannes V</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000923</institution-id><institution>Australian Research Council</institution></institution-wrap></funding-source><award-id>Future Fellowship,FT130101004</award-id><principal-award-recipient><name><surname>Butler</surname><given-names>Lisa M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000950</institution-id><institution>Cancer Council South Australia</institution></institution-wrap></funding-source><award-id>Beat Cancer Fellowship,PRF1117</award-id><principal-award-recipient><name><surname>Butler</surname><given-names>Lisa M</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008719</institution-id><institution>Movember Foundation</institution></institution-wrap></funding-source><award-id>Revolutionary Team Award,MRTA3</award-id><principal-award-recipient><name><surname>Butler</surname><given-names>Lisa M</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>Project Grant,1121057</award-id><principal-award-recipient><name><surname>Selth</surname><given-names>Luke A</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>Project Grant,1100626</award-id><principal-award-recipient><name><surname>Don</surname><given-names>Anthony S</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>Fellowship,1084178</award-id><principal-award-recipient><name><surname>Scott</surname><given-names>Andrew M</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000927</institution-id><institution>Prostate Cancer Foundation of Australia</institution></institution-wrap></funding-source><award-id>Young Investigator Award,YI 1417</award-id><principal-award-recipient><name><surname>Nassar</surname><given-names>Zeyad D</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001184</institution-id><institution>Cure Cancer Australia Foundation</institution></institution-wrap></funding-source><award-id>Project Grant,1164798</award-id><principal-award-recipient><name><surname>Nassar</surname><given-names>Zeyad D</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution>EMBL Australia</institution></institution-wrap></funding-source><award-id>Group Leader Award</award-id><principal-award-recipient><name><surname>Lynn</surname><given-names>David J</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001774</institution-id><institution>University of Sydney</institution></institution-wrap></funding-source><award-id>Robinson Fellowship</award-id><principal-award-recipient><name><surname>Hoy</surname><given-names>Andrew J</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003130</institution-id><institution>Fonds Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>Project Grants G.0841.15 and G.0C22.19N</award-id><principal-award-recipient><name><surname>Swinnen</surname><given-names>Johannes V</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal studies were approved by the Austin Health Animal Ethics Committee (approval number A2015/05311), Heidelberg, Australia, and the University of Adelaide Animal Ethics Committee (approval number M-2019-037), and were carried out in accordance with the recommendations of the National Health and Medical Research Council of Australia.</p></fn><fn fn-type="other"><p>Human subjects: Fresh and archival prostate tissue specimens were collected from men undergoing robotic radical prostatectomy at St. Andrew's Hospital (Adelaide, South Australia) with written informed consent through the Australian Prostate Cancer BioResource. Ethical Approval was provided by the Human Research Ethics Committees of the University of Adelaide (H-2012-016) and St Andrew's Hospital.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Nikitina AS</collab><collab>Sharova EI</collab><collab>Danilenko SA</collab><collab>Butusova TB</collab><collab>Vasiliev AO</collab><collab>Govorov AV</collab><collab>Prilepskaya EA</collab><collab>Pushkar DY</collab><collab>Kostryukova ES</collab></person-group><year iso-8601-date="2017">2017</year><source>Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89223">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89223</ext-link><comment>NCBI The Gene Expression Omnibus, GSE89223</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ding Y</collab><collab>Wu H</collab><collab>Warden C</collab><collab>Steele L</collab><collab>Liu X</collab><collab>Iterson MV</collab><collab>Wu X</collab><collab>Nelson R</collab><collab>Liu Z</collab><collab>Yuan YC</collab><collab>Neuhausen SL</collab></person-group><year iso-8601-date="2016">2016</year><source>Age-Related Gene Expression Changes in Prostate Cancer Patients</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89194">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89194</ext-link><comment>NCBI The Gene Expression Omnibus, GSE89194</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ren S</collab><collab>Peng Z</collab><collab>Mao JH</collab><collab>Yu Y</collab><collab>Yin C</collab><collab>Gao X</collab><collab>Cui Z</collab><collab>Zhang J</collab><collab>Yi K</collab><collab>Xu W</collab><collab>Chen C</collab><collab>Wang F</collab><collab>Guo X</collab><collab>Lu J</collab><collab>Yang J</collab><collab>Wei M</collab><collab>Tian Z</collab><collab>Guan Y</collab><collab>Tang L</collab><collab>Xu C</collab><collab>Wang L</collab><collab>Gao X</collab><collab>Tian W</collab><collab>Wang J</collab><collab>Yang H</collab><collab>Wang J</collab><collab>Sun Y</collab></person-group><year iso-8601-date="2012">2012</year><source>RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22349460">https://www.ncbi.nlm.nih.gov/pubmed/22349460</ext-link><comment>Pubmed, 22349460</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>TCGA</collab></person-group><year iso-8601-date="2019">2019</year><source>The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD)</source><ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/projects/TCGA-PRAD">https://portal.gdc.cancer.gov/projects/TCGA-PRAD</ext-link><comment>National Cancer Institute, TCGA-PRAD</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Tomlins SA</collab><collab>Mehra R</collab><collab>Rhodes DR</collab><collab>Cao X</collab><collab>Wang L</collab><collab>Dhanasekaran SM</collab><collab>Kalyana-Sundaram S</collab><collab>Wei JT</collab><collab>Rubin MA</collab><collab>Pienta KJ</collab><collab>Shah RB</collab><collab>Chinnaiyan AM</collab></person-group><year iso-8601-date="2006">2006</year><source>Integrative Molecular Concepts Modeling of Prostate Cancer Progression</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6099">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6099</ext-link><comment>NCBI The Gene Expression Omnibus, GSE6099</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Grasso CS</collab><collab>Wu YM</collab><collab>Robinson DR</collab><collab>Cao X</collab><collab>Dhanasekaran SM</collab><collab>Khan AP</collab><collab>Quist MJ</collab><collab>Jing X</collab><collab>Lonigro RJ</collab><collab>Brenner JC</collab><collab>Asangani IA</collab><collab>Ateeq B</collab><collab>Chun SY</collab><collab>Siddiqui J</collab><collab>Sam L</collab><collab>Anstett M</collab><collab>Mehra R</collab><collab>Prensner JR</collab><collab>Palanisamy N</collab><collab>Ryslik GA</collab><collab>Vandin F</collab><collab>Raphael BJ</collab><collab>Kunju LP</collab><collab>Rhodes DR</collab><collab>Pienta KJ</collab><collab>Chinnaiyan AM</collab><collab>Tomlins SA</collab></person-group><year iso-8601-date="2012">2012</year><source>The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</ext-link><comment>NCBI The Gene Expression Omnibus, GSE35988</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Taylor BS</collab><collab>Schultz N</collab><collab>Hieronymus H</collab><collab>Gopalan A</collab><collab>Xiao Y</collab><collab>Carver BS</collab><collab>Arora VK</collab><collab>Kaushik P</collab><collab>Cerami E</collab><collab>Reva B</collab><collab>Antipin Y</collab><collab>Mitsiades N</collab><collab>Landers T</collab><collab>Dolgalev I</collab><collab>Major JE</collab><collab>Wilson M</collab><collab>Socci ND</collab><collab>Lash AE</collab><collab>Heguy A</collab><collab>Eastham JA</collab><collab>Scher HI</collab><collab>Reuter VE</collab><collab>Scardino PT</collab><collab>Sander C</collab><collab>Sawyers CL</collab><collab>Gerald WL</collab></person-group><year iso-8601-date="2010">2010</year><source>Integrative genomic profiling of human prostate cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21032">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21032</ext-link><comment>NCBI The Gene Expression Omnibus, GSE21032</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Sboner A</collab><collab>Demichelis F</collab><collab>Calza S</collab><collab>Pawitan Y</collab><collab>Setlur SR</collab><collab>Hoshida Y</collab><collab>Perner S</collab><collab>Adami HO</collab><collab>Fall K</collab><collab>Mucci LA</collab><collab>Kantoff PW</collab><collab>Stampfer M</collab><collab>Andersson SO</collab><collab>Varenhorst E</collab><collab>Johansson JE</collab><collab>Gerstein MB</collab><collab>Golub TR</collab><collab>Rubin MA</collab><collab>Andrén O</collab></person-group><year iso-8601-date="2010">2010</year><source>Molecular Sampling of Prostate Cancer: a dilemma for predicting disease progression</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16560">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16560</ext-link><comment>NCBI The Gene Expression Omnibus, GSE16560</comment></element-citation><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang Q</collab><collab>Li W</collab><collab>Liu XS</collab><collab>Carroll JS</collab><collab>Jänne OA</collab><collab>Keeton EK</collab><collab>Chinnaiyan AM</collab><collab>Pienta KJ</collab><collab>Brown M</collab></person-group><year iso-8601-date="2007">2007</year><source>A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7868">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7868</ext-link><comment>NCBI The Gene Expression Omnibus, GSE7868</comment></element-citation><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Heemers HV</collab><collab>Schmidt LJ</collab><collab>Sun Z</collab><collab>Regan KM</collab><collab>Anderson SK</collab><collab>Duncan K</collab><collab>Wang D</collab><collab>Liu S</collab><collab>Ballman KV</collab><collab>Tindall DJ</collab></person-group><year iso-8601-date="2011">2011</year><source>Identification of an SRF- and androgen-dependent gene signature in prostate cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi</ext-link><comment>NCBI The Gene Expression Omnibus, GSE22606</comment></element-citation><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Asangani IA</collab><collab>Dommeti VL</collab><collab>Wang X</collab><collab>Malik R</collab><collab>Cieslik M</collab><collab>Yang R</collab><collab>Escara-Wilke J</collab><collab>Wilder-Romans K</collab><collab>Dhanireddy S</collab><collab>Engelke C</collab><collab>Iyer MK</collab><collab>Jing X</collab><collab>Wu YM</collab><collab>Cao X</collab><collab>Qin ZS</collab><collab>Wang S</collab><collab>Feng FY</collab><collab>Chinnaiyan AM</collab></person-group><year iso-8601-date="2014">2014</year><source>Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55064">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55064</ext-link><comment>NCBI The Gene Expression Omnibus, GSE55064</comment></element-citation><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Li L</collab><collab>Karanika S</collab><collab>Yang G</collab><collab>Wang J</collab><collab>Park S</collab><collab>Broom BM</collab><collab>Manyam GC</collab><collab>Wu W</collab><collab>Luo Y</collab><collab>Basourakos S</collab><collab>Song JH</collab><collab>Gallick GE</collab><collab>Karantanos T</collab><collab>Korentzelos D</collab><collab>Azad AK</collab><collab>Kim J</collab><collab>Corn PG</collab><collab>Aparicio AM</collab><collab>Logothetis CJ</collab><collab>Troncoso P</collab><collab>Heffernan T</collab><collab>Toniatti C</collab><collab>Lee HS</collab><collab>Lee JS</collab><collab>Zuo X</collab><collab>Chang W</collab><collab>Yin J</collab><collab>Thompson TC</collab></person-group><year iso-8601-date="2016">2016</year><source>Genome-wide analysis of enzalutamide- and/or olaparib-responsive gene expression in prostate cancer cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69249">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69249</ext-link><comment>NCBI The Gene Expression Omnibus, GSE69249</comment></element-citation><element-citation id="dataset13" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang X</collab><collab>Wang B</collab><collab>Soriano R</collab><collab>Zha J</collab><collab>Zhang Z</collab><collab>Modrusan Z</collab><collab>Cunha GR</collab><collab>Gao W</collab></person-group><year iso-8601-date="2006">2006</year><source>Expression profiling of the mouse prostate after castration and hormone replacement</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5901">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5901</ext-link><comment>NCBI The Gene Expression Omnibus, GSE5901</comment></element-citation><element-citation id="dataset14" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Arora VK</collab><collab>Schenkein E</collab><collab>Murali R</collab><collab>Subudhi SK</collab><collab>Wongvipat J</collab><collab>Balbas MD</collab><collab>Shah N</collab><collab>Cai L</collab><collab>Efstathiou E</collab><collab>Logothetis C</collab><collab>Zheng D</collab><collab>Sawyers CL</collab></person-group><year iso-8601-date="2013">2013</year><source>Glucocorticoid Receptor Confers Resistance to Anti-Androgens by Bypassing Androgen Receptor Blockade</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52169">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52169</ext-link><comment>NCBI The Gene Expression Omnibus, GSE52169</comment></element-citation><element-citation id="dataset15" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Pomerantz MM</collab><collab>Li F</collab><collab>Takeda D</collab><collab>Chonkar A</collab><collab>Chabot M</collab><collab>Li Q</collab><collab>Cejas P</collab><collab>Vazquez F</collab><collab>Shivdasani RA</collab><collab>Seo J</collab><collab>Bowden M</collab><collab>Lis R</collab><collab>Hahn WC</collab><collab>Kantoff PW</collab><collab>Brown M</collab><collab>Loda M</collab><collab>Long HW</collab><collab>Freedman ML</collab></person-group><year iso-8601-date="2015">2015</year><source>Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [ChIP-Seq]</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56288">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56288</ext-link><comment>NCBI The Gene Expression Omnibus, GSE56288</comment></element-citation><element-citation id="dataset16" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Glinsky GV</collab><collab>Glinskii AB</collab><collab>Stephenson AJ</collab><collab>Hoffman RM</collab><collab>Gerald WL</collab></person-group><year iso-8601-date="2004">2004</year><source>Gene expression profiling predicts clinical outcome of prostate cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15067324">https://www.ncbi.nlm.nih.gov/pubmed/15067324</ext-link><comment>Pubmed, 15067324</comment></element-citation><element-citation id="dataset17" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Latonen L</collab><collab>Afyounian E</collab><collab>Jylhä A</collab><collab>Nättinen J</collab><collab>Aapola U</collab><collab>Annala M</collab><collab>Kivinummi KK</collab><collab>Tammela TTL</collab><collab>Beuerman RW</collab><collab>Uusitalo H</collab><collab>Nykter M</collab><collab>Visakorpi T</collab></person-group><year iso-8601-date="2018">2018</year><source>Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression</source><ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41467-018-03573-6#Sec31">https://www.nature.com/articles/s41467-018-03573-6#Sec31</ext-link><comment>Peptide Atlas repository, PASS01126</comment></element-citation><element-citation id="dataset18" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Iglesias-Gato D</collab><collab>Thysell E</collab><collab>Tyanova S</collab><collab>Crnalic S</collab><collab>Santos A</collab><collab>Lima TS</collab><collab>Geiger T</collab><collab>Cox J</collab><collab>Widmark A</collab><collab>Bergh A</collab><collab>Mann M</collab><collab>Flores-Morales A</collab><collab>Wikström P</collab></person-group><year iso-8601-date="2018">2018</year><source>The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications</source><ext-link ext-link-type="uri" xlink:href="https://clincancerres.aacrjournals.org/content/24/21/5433">https://clincancerres.aacrjournals.org/content/24/21/5433</ext-link><comment>ProteomeXchange, PXD009868</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-54166-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>